David Lee Johnson
First SEC filing: May 18, 2022 · Latest: May 18, 2022
Insider at
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| Feb. 23, 2026 | VERA | S | 2,579 | $41.98 | $108,266 | 45,727 Direct | -5.34% | Disposed | -27.5% (price as of 2026-10-02) |
| Feb. 20, 2026 | CRBU | A | 45,000 | · | · | 45,000 Direct | · | Acquired | (price as of 2026-10-02) |
| Feb. 4, 2026 | VERA | A | 20,000 | · | · | 48,306 Direct | +70.66% | Acquired | (price as of 2026-10-02) |
| Feb. 4, 2026 | VERA | A | 40,000 | · | · | 40,000 Direct | · | Acquired | (price as of 2026-10-02) |
| Feb. 20, 2025 | CRBU | A | 40,500 | · | · | 40,500 Direct | · | Acquired | (price as of 2026-10-02) |
| Feb. 18, 2025 | VERA | A | 26,900 | · | · | 26,900 Direct | · | Acquired | (price as of 2026-10-02) |
| Feb. 18, 2025 | VERA | A | 53,800 | · | · | 53,800 Direct | · | Acquired | (price as of 2026-10-02) |
| July 1, 2024 | VERA | A | 160,000 | · | · | 160,000 Direct | · | Acquired | (price as of 2026-10-02) |
| Feb. 20, 2024 | CRBU | A | 39,500 | · | · | 39,500 Direct | · | Acquired | (price as of 2026-10-02) |
| Feb. 21, 2023 | CRBU | A | 21,500 | · | · | 21,500 Direct | · | Acquired | (price as of 2026-10-02) |
| May 18, 2022 | CRBU | A | 44,000 | · | · | 44,000 Direct | · | Acquired | (price as of 2026-10-02) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II) Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| Feb. 20, 2026 | CRBU | Option to purchase Common Stock | Common Stock | $1.80 | Feb. 19, 2036 | 45,000 | Acquired |
| Feb. 4, 2026 | VERA | Stock Option (right to buy) | Class A Common Stock | $42.74 | Feb. 3, 2036 | 40,000 | Acquired |
| Feb. 20, 2025 | CRBU | Option to purchase Common Stock | Common Stock | $1.41 | Feb. 19, 2035 | 40,500 | Acquired |
| Feb. 18, 2025 | VERA | Stock Option (right to buy) | Class A Common Stock | $29.18 | Feb. 17, 2035 | 53,800 | Acquired |
| July 1, 2024 | VERA | Stock Option (right to buy) | Class A Common Stock | $36.29 | June 30, 2034 | 160,000 | Acquired |
| Feb. 20, 2024 | CRBU | Option to purchase Common Stock | Common Stock | $6.81 | Feb. 19, 2034 | 39,500 | Acquired |
| Feb. 21, 2023 | CRBU | Option to purchase Common Stock | Common Stock | $6.12 | Feb. 20, 2033 | 21,500 | Acquired |
| May 18, 2022 | CRBU | Option to purchase Common Stock | Common Stock | $9.12 | May 17, 2032 | 44,000 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2025 | $510,000 | · | $784,942 | $1,137,870 | $285,600 | · | $3,000 | $2,721,412 |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.